# FDA 483 - Kailash K. Jindal, MD, PI - June 27, 2014

Source: https://www.globalkeysolutions.net/records/483/kailash-k-jindal-md-pi/8394457a-875e-4fcf-885e-b670ab75804b

> FDA 483 for Kailash K. Jindal, MD, PI on June 27, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kailash K. Jindal, MD, PI
- Inspection Date: 2014-06-27
- Product Type: drugs
- Office Name: Center for Veterinary Medicine
- Summary: An FDA inspection of Kailash K. Jindal, MD, PI, a clinical investigator in Edmonton, Alberta, revealed significant deviations from the investigational plan. Observations included failure to withhold study drug when subjects were prescribed antibiotics/antifungals and enrollment of a subject with an active bacterial infection, both contrary to protocol requirements. These issues indicate a lack of adherence to study protocols during the clinical investigation.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/laura-lee-staples/db5cd429-7db7-4553-9d48-e52ec7d3da66)

Company: https://www.globalkeysolutions.net/companies/kailash-k-jindal-md-pi/a2705eb3-aaf9-4da1-9dad-c4dd0798d20d

Office: https://www.globalkeysolutions.net/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4